Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT00588835
Eligibility Criteria:
Inclusion Criteria:
* between 18 and 75 years of age
* able and willing to sign informed consent form
* indication for treatment with CE regimen
* subject is expected to receive at least 2 cycles of CE regimen
* able to swallow capsules
Exclusion Criteria:
* history of sensitivity/idiosyncrasy to aprepitant or excipients
* condition that might interfere with drug absorption, distribution metabolism or excretion.
* history or current abuse of drugs, alcohol or solvents
* inability to understand the nature and extent of the trial and procedures
* participation in a drug trial within 30 days prior to the first dose
* febrile illness within 3 days before the first dose
* concomitant use of agents that are known to interfere with aprepitant pharmacokinetics
* abnormal liver or renal function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00588835
Study Brief:
Protocol Section:
NCT00588835